期刊： CANCER GENE THERAPY, 2022; 29 (1)
microRNAs (miRNAs) have been revealed to participate in some oral cancers and are proved to be effective. In the present study, we tried to explore th......
期刊： CANCER GENE THERAPY, 2022; 29 (1)
Significantly high-expressed circFLNA has been found in various cancer cell lines, but not in lung cancer. Therefore, this study aimed to explore the ......
期刊： CANCER GENE THERAPY, 2022; 29 (3-4)
Long non-coding RNAs (lncRNAs) were recently recognized to vitally function in a variety of cancer cellular events, including epithelial-mesenchymal t......
期刊： CANCER GENE THERAPY, 2022; 29 (8-9)
Autophagy is the predominant self-eating catabolic pathway activated in response to nutrient starvation and hypoxia within the microenvironment of var......
期刊： CANCER GENE THERAPY, 2022; 29 (11)
Drug resistance is a key factor in the treatment failure of acute myeloid leukemia (AML). Nuclear factor E2-related factor 2 (Nrf2) plays a crucial ro......
期刊： CANCER GENE THERAPY, 2022; 29 (7)
N-6-methyladenosine (m(6)A) RNA methylation and its associated methyltransferase METTL3 play an important role in tumorigenesis of a series of tumors.......
期刊： CANCER GENE THERAPY, 2022; 29 (8-9)
Alpha-synuclein (alpha-syn), encoded by the SNCA gene, is a major participant in the pathophysiology of Parkinson's disease (PD). Its functions have b......
期刊： CANCER GENE THERAPY, 2022; 29 (11)
The homeobox gene family encodes transcription factors that are essential for cell growth, proliferation, and differentiation, and its dysfunction is ......
期刊： CANCER GENE THERAPY, 2022; 29 (8-9)
The incidence of breast cancer (BC) has been increasing each year, and BC is now the most common malignant tumor in women. Among the numerous BC subty......
期刊： CANCER GENE THERAPY, 2022; 29 (8-9)
Macrophages plays a vital role in the development of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), but the polarization of ......
期刊： CANCER GENE THERAPY, 2022; 29 (10)
Alternative splicing (AS) is a gene regulatory mechanism that drives protein diversity and dysregulation of AS plays a significant role in tumorigenes......
期刊： CANCER GENE THERAPY, 2022; 29 (8-9)
Endometrial cancer (EC) is a group of epithelial malignant tumors that occur in the endometrium. The specific pathogenesis is not revealed, hence, the......
期刊： CANCER GENE THERAPY, 2022; 29 (10)
Mitochondrial serine hydroxymethyltransferase (SHMT2) catalyzes the conversion of serine to glycine and concomitantly produces one-carbon units to sup......
期刊： CANCER GENE THERAPY, 2022; 29 (8-9)
Somatic copy number alterations (SCNA), which are widespread in cancer, can predict the efficacy of immune checkpoint inhibitors in non-small-cell lun......
期刊： CANCER GENE THERAPY, 2022; 29 (11)
The Apoptosis Stimulating Protein of p53 2 (ASPP2) is a heterozygous insufficient tumor suppressor; however, its molecular mechanism(s) in tumor suppr......
